Latest Insider Transactions at Vaxxinity, Inc. (VAXX)
This section provides a real-time view of insider transactions for Vaxxinity, Inc. (VAXX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vaxxinity, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vaxxinity, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
James Chui Director |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$56,000
$7.89 P/Share
|
|
Nov 18
2021
|
Peter Diamandis Director |
BUY
Other acquisition or disposition
|
Direct |
76,923
+50.0%
|
-
|
|
Nov 18
2021
|
Peter Diamandis Director |
SELL
Other acquisition or disposition
|
Indirect |
76,923
-100.0%
|
-
|
|
Nov 16
2021
|
Gregory R Blatt Director |
BUY
Other acquisition or disposition
|
Direct |
76,923
+50.0%
|
-
|
|
Nov 16
2021
|
Gregory R Blatt Director |
SELL
Other acquisition or disposition
|
Indirect |
76,923
-100.0%
|
-
|
|
Nov 15
2021
|
Prime Movers Lab Fund I LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
9,738,192
+50.0%
|
-
|
|
Nov 15
2021
|
Prime Movers Lab Fund I LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
8,289,122
+50.0%
|
-
|
|
Nov 15
2021
|
Ulo Palm Officer |
BUY
Open market or private purchase
|
Indirect |
450
+50.0%
|
$5,850
$13.0 P/Share
|
|
Nov 15
2021
|
Gregory R Blatt Director |
BUY
Open market or private purchase
|
Indirect |
76,923
+50.0%
|
-
|
|
Nov 15
2021
|
Gregory R Blatt Director |
BUY
Conversion of derivative security
|
Indirect |
836,737
+50.0%
|
-
|
|
Nov 15
2021
|
Peter Diamandis Director |
BUY
Open market or private purchase
|
Indirect |
76,923
+50.0%
|
-
|
|
Nov 15
2021
|
Peter Diamandis Director |
BUY
Conversion of derivative security
|
Indirect |
271,655
+50.0%
|
-
|
|
Nov 15
2021
|
United Biomedical Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,212,495
+50.0%
|
-
|
|
Nov 15
2021
|
United Biomedical Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
247,050
+0.48%
|
-
|
|
Nov 15
2021
|
Mei Mei Hu Director |
BUY
Conversion of derivative security
|
Indirect |
4,731,200
+33.49%
|
-
|
|
Nov 15
2021
|
Lou Reese Director |
BUY
Conversion of derivative security
|
Indirect |
4,731,200
+33.49%
|
-
|
|
Nov 12
2021
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
17,500
+50.0%
|
$227,500
$13.82 P/Share
|
|
Nov 12
2021
|
Lou Reese Director |
BUY
Open market or private purchase
|
Direct |
17,500
+50.0%
|
$227,500
$13.82 P/Share
|